225 related articles for article (PubMed ID: 10955700)
1. Low-dose inhaled budesonide once or twice daily for 27 months in children with mild asthma.
Jónasson G; Carlsen KH; Jonasson C; Mowinckel P
Allergy; 2000 Aug; 55(8):740-8. PubMed ID: 10955700
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids.
Jónasson G; Carlsen KH; Blomqvist P
Eur Respir J; 1998 Nov; 12(5):1099-104. PubMed ID: 9864004
[TBL] [Abstract][Full Text] [Related]
3. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids.
Shapiro GG; Mendelson LM; Pearlman DS
Ann Allergy Asthma Immunol; 2001 Jun; 86(6):633-40. PubMed ID: 11428735
[TBL] [Abstract][Full Text] [Related]
4. Maximal response plateau to methacholine as a reliable index for reducing inhaled budesonide in moderate asthma.
Prieto L; Gutiérrez V; Morales C
Eur Respir J; 1999 Jun; 13(6):1236-44. PubMed ID: 10445596
[TBL] [Abstract][Full Text] [Related]
5. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma.
Banov CH; Howland WC; Lumry WR
Ann Allergy Asthma Immunol; 2001 Jun; 86(6):627-32. PubMed ID: 11428734
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled dose-response study with budesonide Turbuhaler in Japanese asthma patients. Japanese Pulmicort Turbuhaler study group.
Miyamoto T; Takahashi T; Nakajima S; Makino S; Yamakido M; Mano K; Nakashima M; Tollemar U; Selroos O
Respirology; 2000 Sep; 5(3):247-56. PubMed ID: 11022987
[TBL] [Abstract][Full Text] [Related]
7. Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults.
Aziz I; Wilson AM; Lipworth BJ
Chest; 2000 Oct; 118(4):1049-58. PubMed ID: 11035676
[TBL] [Abstract][Full Text] [Related]
8. An inhaled steroid improves markers of airway inflammation in patients with mild asthma.
Jatakanon A; Lim S; Chung KF; Barnes PJ
Eur Respir J; 1998 Nov; 12(5):1084-8. PubMed ID: 9864001
[TBL] [Abstract][Full Text] [Related]
9. Low-dose budesonide improves exercise-induced bronchospasm in schoolchildren.
Jónasson G; Carlsen KH; Hultquist C
Pediatr Allergy Immunol; 2000 May; 11(2):120-5. PubMed ID: 10893016
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 3 different doses of budesonide and placebo on the early asthmatic response to inhaled allergen.
Swystun VA; Bhagat R; Kalra S; Jennings B; Cockcroft DW
J Allergy Clin Immunol; 1998 Sep; 102(3):363-7. PubMed ID: 9768574
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a clinical algorithm involving serum eosinophil cationic protein for guiding the anti-inflammatory treatment of bronchial asthma in childhood.
Prehn A; Seger RA; Torresani T; Molinari L; Sennhauser FH
Pediatr Allergy Immunol; 2000 May; 11(2):87-94. PubMed ID: 10893010
[TBL] [Abstract][Full Text] [Related]
12. Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control.
Worth H; Muir JF; Pieters WR
Respiration; 2001; 68(5):517-26. PubMed ID: 11694816
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of budesonide inhalation suspension in infants and young children with persistent asthma. Budesonide Inhalation Suspension Study Group.
Mellon M
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):191-9. PubMed ID: 10518846
[TBL] [Abstract][Full Text] [Related]
14. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
Lönnkvist K; Hellman C; Lundahl J; Halldén G; Hedlin G
J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
[TBL] [Abstract][Full Text] [Related]
15. Hypodense eosinophil number relates to clinical severity, airway hyperresponsiveness and response to inhaled corticosteroids in asthmatic subjects.
Kuo HP; Yu TR; Yu CT
Eur Respir J; 1994 Aug; 7(8):1452-9. PubMed ID: 7957830
[TBL] [Abstract][Full Text] [Related]
16. Patient compliance in a clinical trial with inhaled budesonide in children with mild asthma.
Jónasson G; Carlsen KH; Sødal A; Jonasson C; Mowinckel P
Eur Respir J; 1999 Jul; 14(1):150-4. PubMed ID: 10489843
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of once- and twice-daily administration of budesonide via Turbuhaler as initial therapy in patients with mild persistent asthma.
Herjavecz I; Blomqvist P; Serrano A
Respir Med; 1999 Apr; 93(4):230-5. PubMed ID: 10464886
[TBL] [Abstract][Full Text] [Related]
18. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma.
Shapiro G; Bronsky EA; LaForce CF; Mendelson L; Pearlman D; Schwartz RH; Szefler SJ
J Pediatr; 1998 Jun; 132(6):976-82. PubMed ID: 9627589
[TBL] [Abstract][Full Text] [Related]
19. Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma.
Corren J; Berkowitz R; Murray JJ; Prenner B
Int J Clin Pract; 2003 Sep; 57(7):567-72. PubMed ID: 14529054
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of once-daily versus twice-daily administration of budesonide by Turbuhaler(R) in children with stable asthma.
Möller C; Strömberg L; Oldaeus G; Arweström E; Kjellman M
Pediatr Pulmonol; 1999 Nov; 28(5):337-43. PubMed ID: 10536064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
